Literature DB >> 27711765

CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering.

Amrita Singh1, Debojyoti Chakraborty, Souvik Maiti.   

Abstract

The CRISPR-Cas9 system has revolutionized the process of making changes to the DNA sequence of organisms. Relying on a simplistic model of RNA guided DNA binding and cleavage, this molecular toolbox has found application in nearly every branch of biological sciences. The story of CRISPR-Cas9 is one of discovery and development where a component of bacterial adaptive immunity has been harnessed to address important biological questions using significant inputs from physicochemical structure-function studies. In this review, we trace the evolution of CRISPR-Cas9 from its predecessor genome editing tools and document its current status with an emphasis on chemical biology aspects of modulating its activity to generate a potent tool for gene therapy applications.

Mesh:

Substances:

Year:  2016        PMID: 27711765     DOI: 10.1039/c6cs00197a

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  3 in total

Review 1.  Biology and Mechanisms of Action of the Vitamin D Hormone.

Authors:  J Wesley Pike; Sylvia Christakos
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

2.  Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing.

Authors:  Sundaram Acharya; Arpit Mishra; Deepanjan Paul; Asgar Hussain Ansari; Mohd Azhar; Manoj Kumar; Riya Rauthan; Namrata Sharma; Meghali Aich; Dipanjali Sinha; Saumya Sharma; Shivani Jain; Arjun Ray; Suman Jain; Sivaprakash Ramalingam; Souvik Maiti; Debojyoti Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

Review 3.  Programmable Genome Editing Tools and their Regulation for Efficient Genome Engineering.

Authors:  Tuhin Kumar Guha; Alvan Wai; Georg Hausner
Journal:  Comput Struct Biotechnol J       Date:  2017-01-12       Impact factor: 7.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.